A pharmaceutical company needed timely and frequent feedback from a panel of KOLs around the creation of a patient database to collect real-world data post-product launch.

ExtendMed saved them more than 200 hours by shifting away from traditional meetings. Our platform cut the cost of soliciting the perspectives of these thought leaders by two-thirds.

A top 20 multinational pharmaceutical company needed to reduce costs and increase communication effectiveness across active trial sites, from trial start to completion, in line with protocol requirements.

ExtendMed achieved over 80% site participation in these virtual meetings, shrunk participant commitment from days to 60 minutes and the planning process from six months to two. Cost savings were reported at 66% versus a traditional face-to-face event. Internal staff reduced planning time by half and evaluations remained as strong as in-person events.

A mid-size pharmaceutical company lacked marketing focus and wanted to use a group of KOLs to assess their marketing strategy.

Using ExtendMed to streamline market testing between external experts and the commercial team, the company began monthly outreach to build stronger specialist relationships, differentiated its position in a competitive market, and enabled clinical experts to provide feedback at their convenience—better noting the actions taken from their input.